Podcast Summary: "Rebroadcast: The Truth About Johnson & Johnson"

Apple News Today – February 28, 2026
Host: Shamita Basu
Guest: Gardner Harris (Investigative Journalist, Author of No More: The Dark Secrets of Johnson & Johnson)

Overview

In this special rebroadcast, host Shamita Basu sits down with investigative journalist Gardner Harris. Their conversation centers on Johnson & Johnson's century-spanning influence over American healthcare, the company's dark history with harmful products, its role in crises such as asbestos-contaminated talc and the opioid epidemic, the failure of regulatory oversight, and the immense challenge of holding powerful corporations accountable. Harris’s new book, No More: The Dark Secrets of Johnson & Johnson, serves as the foundation for the discussion, revealing how deep-seated systemic issues threaten public trust in healthcare and regulatory institutions.

Key Discussion Points & Insights

Johnson & Johnson: An American Icon with a Dark Side

(02:23-03:42)

• Harris contextualizes J&J as not just the world's largest healthcare products conglomerate, but as a touchstone of American capitalism. With $89 billion in revenue and a rare AAA credit rating, J&J’s products are omnipresent.
• Despite its trusted public image, Harris contends J&J has caused serious harm: "J and J has knowingly contributed to the deaths and grievous injuries of millions." (02:43)
• Many believe Purdue Pharma and the Sacklers were the sole driving force behind the opioid epidemic; Harris insists J&J's role was at least equally significant, if not greater.

The Baby Powder Scandal: Asbestos & Denials

(04:39-11:32)

• Origins: J&J began selling talc-based baby powder in the 1800s. Talc and asbestos are geologically linked; elimination of asbestos from talc is essentially impossible. (04:59-07:15)
• Public Health Crisis: By the mid-20th century, even minimal asbestos exposure was found to cause mesothelioma. Despite industry-wide moves to remove asbestos, J&J’s baby powder remained contaminated.
• Regulatory Evasion: In the 1970s, FDA eyed stricter talc testing, but the industry, led by J&J, lobbied against it and was allowed to self-regulate. (07:15)
• Cover-Up Revealed: Documents uncovered through lawsuits showed J&J kept evidence of asbestos contamination secret for decades; a 2009 lawsuit began a cascade of legal action after company denials were upended by insider knowledge (08:06-08:55).
• Legal Fallout: A succession of lawsuits exposed J&J’s deception, with a $75 million settlement in one early case and billions paid out in later judgments, including over $4 billion to women with ovarian cancer. (09:55)
• Discontinuation: By 2020, J&J ceased U.S. and Canadian sales of talc powder, citing “misinformation” rather than safety; finally, the global halt came in 2023. A cornstarch version is now sold.
• Scale of Harm:
  • "Something like 15% of women with ovarian cancer in the United States got it from talc-based powders… probably around 100,000 women died from ovarian cancer alone because of Johnson's baby powder." – Gardner Harris (10:49)

The Opioid Crisis: More than Just Purdue

(12:05-20:14)

• J&J’s Hidden Influence: While Purdue is often blamed, Harris says, "roughly 60% [of the opioid victims] had a Johnson and Johnson product in their system.” (12:46)
• Supplying the Market: J&J supplied nearly all natural opioid ingredients (via an Australian subsidiary) used in the U.S., including Purdue’s OxyContin.
• Fentanyl Roots: J&J invented and marketed the first fentanyl patch (Duragesic)—originally approved only for cancer or post-surgical patients but later aggressively pushed for broader, more lucrative uses.
• Misleading Marketing: J&J promoted fentanyl as “non-addictive”—a claim Harris calls “hard to even conceive of… But that's what Johnson and Johnson did for years and years and years. So of course, death soared.” (16:22)
• Regulatory Blindness: The FDA failed to intercede, despite clear signals of mass harm and misleading promotions; OxyContin scripts plateaued after early exposés, but J&J’s similar tactics kept opioid deaths rising.

Regulatory Failure: The Enfeebled FDA

(17:21-20:14; 31:16-35:30)

• Structural Weakness: Since 1992, under budget pressures, the FDA began taking industry user fees, fundamentally shifting the regulator’s allegiance. Investigations of drug makers stopped, the FDA “put its criminal investigators in a lockbox.” (17:42)
• Passive Policing: Despite knowing of corporate malfeasance and sometimes issuing warning letters, the FDA consistently failed to pursue criminal charges or strong enforcement. “The FDA did nothing about it because by then the FDA had been bought and paid for.” (19:59)
• Cozy Relationship: Harris details instances where J&J “saved” the FDA in funding crises, and how, in exchange, the agency took actions that benefited J&J, even attesting to product safety in the midst of legal battles. (31:40-35:30)
  • “So what you see is an agency that is partnered and deeply invested in the safety of Johnson and Johnson and doing not only nothing to police this bad behavior, but actually enabling it.” – Gardner Harris (35:16)

Other J&J Failures: Implants, Mesh, and COVID Vaccine

(21:19-26:33)

• Implants & Mesh Disasters: J&J’s metal-on-metal hip implants and vaginal mesh products caused global harm, with the latter leaving “hundreds of thousands of women around the world… unable to have vaginal sex.” (21:54)
• COVID-19 Vaccine: J&J viewed the vaccine as a shot at redemption. But (1) its design relied on a method known to cause excess bleeding and clotting, (2) manufacturing at Emergent BioSolutions was disastrous, with cross-contamination of vaccines, (3) emerging side effects—including blood clots and potential neurological harm—were far in excess of tolerable vaccine risk ranges. FDA eventually revoked its authorization. (21:54-26:33)

J&J’s Corporate Strategy: Image vs. Reality

(26:33-31:16)

• Corporate Stonewalling: J&J systematically refused engagement and comment, a practice dating back to the 1970s. Harris explains, “they do not take prisoners... I expect them to come after us.” (28:32)
• Media Manipulation: The company used its colossal advertising budget to threaten and sometimes quash critical stories, maintaining a “pristine image” by exploiting financial dependence of major news organizations. (29:55)
  • “If you run this story, we are pulling all of our ads. And in case after case, the stories got pulled… Corporate media simply didn’t want to take it on.” (30:48)

Declining Public Trust & Fundamental Systemic Issues

(35:30-38:33)

• Public Distrust: Harris expresses empathy for increasing skepticism toward U.S. health institutions, citing numerous examples where agencies and companies concealed harm.
• Criminal Evasion: Even when companies hid life-and-death data from regulators, consequences were minimal—no prosecutions, no deep reform.
• Transparency Solution: Harris is working to make thousands of pages of source documents publicly available, enabling independent scrutiny.

Regulatory Reform & Solutions

(38:33-43:05)

• FDA Leadership: Harris is cautiously optimistic that controversial figures like Robert F. Kennedy, Jr. might finally challenge entrenched industry power, particularly by addressing the FDA’s compromised funding model.
• Systemic Overhaul Suggestions:
  • Separate regulatory approval from post-market safety oversight, similar to aviation’s FAA/NTSB split, to prevent institutional conflict of interest.
  • Establish a genuine “policing” mechanism in healthcare, with a transparent, public-focused mandate.
  • End the financial enmeshment of doctors with industry: “Work for industry or work for your patients, but you can’t do both. That’s probably my most important piece of advice.” (40:57)
• Vision: Harris’s book serves as both a condemnation and a “guidebook” for navigating a healthcare ecosystem rife with concealed dangers.

Memorable Quotes & Moments

• “From the start of your life, it's been a part of your life... Johnson's baby powder was its most iconic product—the scent is the most recognized fragrance on the planet.” — Shamita Basu & Gardner Harris (00:44-01:19)
• “Johnson and Johnson has knowingly contributed to the deaths and grievous injuries of millions.” — Gardner Harris (02:43)
• “The problem with the system... is that it is corrupt through and through.” — Gardner Harris (36:48)
• “If your doctor wants to take money from Johnson and Johnson, that's fine. They can do that. They just can't treat patients anymore.” — Gardner Harris (42:25)
• “They do not take prisoners. And, you know, this book is supposed to come out. We'll see how long it's available because I expect them to come after us.” — Gardner Harris (28:32)

Timestamps for Important Segments

• J&J’s Historical Context & Scale – 02:23
• Talc & Asbestos Scandal Unpacked – 04:39–11:32
• Opioid Crisis & J&J’s Role – 12:05–20:14
• FDA Regulatory Failures – 17:21; 31:16–35:30
• COVID-19 Vaccine: What Went Wrong – 21:19–26:33
• Corporate Response and Legal Culture – 26:33–31:16
• Declining Trust; Systemic Corruption – 35:30–38:33
• Reforming the System: Solutions & Final Thoughts – 38:33–43:05

Conclusion

This episode leverages Gardner Harris’s deep reporting to expose the vast, often hidden costs of J&J’s business practices—and the failures of U.S. regulatory agencies to protect public health. By drawing clear lines between industry influence, regulatory capture, and patient harm, it compels listeners to question both iconic brands and the systems meant to safeguard society, while offering concrete ideas for reform. Harris’s investigation stands as both warning and roadmap for anyone navigating healthcare in America.